Concepedia

Publication | Closed Access

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

DOI

352

Citations

19

References

2008

Year

Katherine Robinson, Michael E. Williams, Richard H. van der Jagt, Philip Cohen, Jordan A. Herst, Anil Tulpule, Lee S. Schwartzberg, Bernard Lemieux, Bruce D. Cheson
Journal of Clinical Oncology

Abstract

Bendamustine plus rituximab is an active combination in patients with relapsed indolent and mantle cell lymphoma.

References

YearCitations

Page 1